CASI Pharmaceuticals, Inc. (CASI)
0.89
-0.04
(-4.30%)
USD |
NASDAQ |
Dec 09, 10:56
CASI Pharmaceuticals EPS Diluted (Quarterly): -0.6781 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sinovac Biotech Ltd. | -- |
| China Pharma Holdings, Inc. | -0.1682 |
| Zai Lab Ltd. | -0.3267 |
| Adagene, Inc. | -- |
| Adlai Nortye Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.88M |
| Revenue (Quarterly) | 3.075M |
| Total Expenses (Quarterly) | 13.96M |
| Enterprise Value | 33.28M |
| Gross Profit Margin (Quarterly) | 22.96% |
| Profit Margin (Quarterly) | -353.9% |
| Earnings Yield | -355.3% |
| Normalized Earnings Yield | -348.07 |